{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:31:45Z","timestamp":1790836305866,"version":"4.1.0"},"reference-count":65,"publisher":"Walter de Gruyter GmbH","issue":"5","license":[{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T00:00:00Z","timestamp":1600300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2016\/23\/B\/NZ6\/01497"],"award-info":[{"award-number":["2016\/23\/B\/NZ6\/01497"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010438","name":"Poznan University of Medical Sciences","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pattern recognition receptors (PRRs) are a pivotal part of the immune system. They are distributed in almost every site of higher organisms, able to recognize foreign pathogens or unwanted remnants of metabolism and mount innate immune response. Moreover, PRRs create bridging signaling to initiate adaptive immunity. The liver being the largest organ of the body, exposed to myriads of foreign substances often being immunogenic, is well equipped with PRRs. They act as sentinels of the organ, both in health and disease. In viral hepatitis C at least two of them, RIG-1 and TLR3 sense HCV, induce protective interferon production and create proinflammatory status. The hepatitis B virus is apparently invisible to PRRs, which has recently been denied. Besides, they are active in the course of infection. In liver injury and hepatic fibrogenesis Toll-like receptors (TLRs), predominantly TLR4, TLR3 and TLR9 are associated with gut microflora-related products and DNA from dying hepatocytes, lead to the activation of hepatic stellate cells. The latter initiate production of fibrillar collagens, the main agents forming hepatic fibrosis. Tumor cells of primary liver cancer also express PRRs, mainly TLRs. In concert with non-resolving liver inflammation, they are considered pivotal factors leading to carcinogenesis.<\/jats:p>","DOI":"10.1007\/s00005-020-00595-1","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T14:03:52Z","timestamp":1600351432000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Pattern Recognition Receptors: Significance of Expression in the Liver"],"prefix":"10.2478","volume":"68","author":[{"given":"Jan","family":"\u017beromski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Kierepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Brzezicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arleta","family":"Kowala-Piaskowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Mozer-Lisewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,9,17]]},"reference":[{"key":"595_CR1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.it.2018.05.002","volume":"39","author":"TE Adolph","year":"2018","unstructured":"Adolph TE, Grander C, Moschen AR et al (2018) Liver-microbiome axis in health and disease. Rev Trends Immunol 39:712\u2013723","journal-title":"Rev Trends Immunol"},{"key":"595_CR2","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","volume":"124","author":"S Akira","year":"2006","unstructured":"Akira S, Uematsu S, Takeuchi O (2006) Pathogen recognition and innate immunity. Cell 124:783\u2013801","journal-title":"Cell"},{"key":"595_CR3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.sjbs.2016.11.010","volume":"26","author":"MR Al-Anazi","year":"2019","unstructured":"Al-Anazi MR, Nazir N, Abdo AA et al (2019) Genetic variations of NOD2 and MD2 genes in hepatitis B infection. Saudi J Biol Sci 26:270\u2013280","journal-title":"Saudi J Biol Sci"},{"key":"595_CR4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-0037-1601350","volume":"37","author":"F Alegre","year":"2017","unstructured":"Alegre F, Pelegrini P, Feldstein AE (2017) Inflammasomes in liver fibrosis. Semin Liver Dis 37:119\u2013127","journal-title":"Semin Liver Dis"},{"key":"595_CR5","first-page":"192543","volume":"2010","author":"T Aoyama","year":"2010","unstructured":"Aoyama T, Paik YH, Seki E (2010) Toll-like receptor signaling and liver fibrosis. Gastroenterol Res 2010:192543","journal-title":"Gastroenterol Res"},{"key":"595_CR6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1089\/vim.2016.0045","volume":"29","author":"AA Askari","year":"2016","unstructured":"Askari AA, Nostratabadi R, Khaleghinia M et al (2016) Evaluation of NLRC4, NLRP1 and NLRP3 as components of inflammasomes, in chronic hepatitis B virus infected patients. Viral Immunol 29:496\u2013501","journal-title":"Viral Immunol"},{"key":"595_CR7","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/sj.icb.7100098","volume":"85","author":"A Banerjee","year":"2007","unstructured":"Banerjee A, Gerondakis S (2007) Coordinating TLR-activated signaling pathways in cells of the immune system. Immunol Cell Biol 85:420\u2013424","journal-title":"Immunol Cell Biol"},{"key":"595_CR8","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1084\/jem.20050914","volume":"202","author":"FJ Barrat","year":"2005","unstructured":"Barrat FJ, Meeker T, Gregorio J et al (2005) Nucleic acids of mammalian origin can act as endogenous ligands for toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202:1131\u20131139","journal-title":"J Exp Med"},{"key":"595_CR9","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1053\/j.gastro.2018.01.030","volume":"154","author":"C Boni","year":"2018","unstructured":"Boni C, Vecchi A, Rossi M et al (2018) TLR7 agonist increases responses of hepatitis B virus specific T cells and natural killer cells in patients with chronic hepatitis B treated with nucleos(T)ide analogues. Gastroenterology 154:1764\u20131777","journal-title":"Gastroenterology"},{"key":"595_CR10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jhep.2019.05.031","volume":"71","author":"M Bonnin","year":"2019","unstructured":"Bonnin M, Fares N, Testoni B et al (2019) Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis. J Hepatol 71:763\u2013772","journal-title":"J Hepatol"},{"key":"595_CR11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molimm.2018.05.005","volume":"99","author":"G Chi","year":"2018","unstructured":"Chi G, Feng XX, Ru YX et al (2018) TLR2\/4 ligand amplified liver inflammation promotes initiation of autoimmune hepatitis due to sustained IL-6\/IL-12\/IL-4\/IL-25 expression. Mol Immunol 99:171\u2013181","journal-title":"Mol Immunol"},{"key":"595_CR12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","volume":"21","author":"DH Dapito","year":"2012","unstructured":"Dapito DH, Mencin A, Gwak GY et al (2012) Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21:504\u2013516","journal-title":"Cancer Cell"},{"key":"595_CR13","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3748\/wjg.v12.i8.1198","volume":"12","author":"A Dolganiuc","year":"2006","unstructured":"Dolganiuc A, Garcia C, Kodys K et al (2006) Distinct Toll-like receptor expression in monocytes and T cells in chronic HCV infection. World J Gastroenterol 12:1198\u20131204","journal-title":"World J Gastroenterol"},{"key":"595_CR14","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2004.08.067","volume":"127","author":"A Dolganiuc","year":"2004","unstructured":"Dolganiuc A, Oak S, Kodys K et al (2004) Hepatitis C core and nonstructural 3 proteins trigger Toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology 127:1513\u20131524","journal-title":"Gastroenterology"},{"key":"595_CR15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ijpddr.2018.10.006","volume":"8","author":"M Ernest","year":"2018","unstructured":"Ernest M, Hunja C, Arakura Y et al (2018) The Toll-like receptor 2 agonist PEG-Pam2Cyus as an immunochemoprophylactic and immunochemotherapeutic against the liver and transmission stages of malaria parasites. Int J Parasitol Drugs Drug Resist 8:451\u2013458","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"595_CR16","first-page":"173","volume":"24","author":"AM EzzEl-Din","year":"2017","unstructured":"EzzEl-Din AM, Galal SH, Ahmed AO et al (2017) Toll-like receptor 3 polymorphisms and hepatitis B virus infection. Egypt J Immunol 24:173\u2013185","journal-title":"Egypt J Immunol"},{"key":"595_CR17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000489966","volume":"10","author":"S Faure-Dupuy","year":"2018","unstructured":"Faure-Dupuy S, Vegna S, Aillot L et al (2018) Characterization of pattern recognition receptor expression and functionality in liver primary cells and derived cell lines. J Innate Immunol 10:339\u2013348","journal-title":"J Innate Immunol"},{"key":"595_CR18","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655\u20131669","journal-title":"Gastroenterology"},{"key":"595_CR19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbrc.2008.08.096","volume":"376","author":"E Gabele","year":"2008","unstructured":"Gabele E, Muhlbauer M, Dorn C et al (2008) Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. Biochem Biophys Res Commun 376:271\u2013276","journal-title":"Biochem Biophys Res Commun"},{"key":"595_CR20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI83885","volume":"126","author":"I Garcia-Martinez","year":"2016","unstructured":"Garcia-Martinez I, Santoro N, Chen Y et al (2016) Hepatocyte mitochondrial DNA drives nonalcocholic steatohepatitis by activation of TLR9. J Clin Investig 126:859\u2013864","journal-title":"J Clin Investig"},{"key":"595_CR21","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1128\/JVI.02008-08","volume":"83","author":"H Guo","year":"2009","unstructured":"Guo H, Jiang D, Ma D et al (2009) Activation of pattern recognition receptor-mediated innate immunity inhibits the replication of hepatitis B virus in human hepatocyte-derived cells. J Virol 83:847\u2013858","journal-title":"J Virol"},{"key":"595_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-1536-3-21","volume":"3","author":"J Guo","year":"2010","unstructured":"Guo J, Friedman SL (2010) Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis. Fibrogenesis Tissue Repair 3:21","journal-title":"Fibrogenesis Tissue Repair"},{"key":"595_CR23","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s00705-018-3893-8","volume":"163","author":"S Hamdy","year":"2018","unstructured":"Hamdy S, Osman AM, Zakaria ZA et al (2018) Association of Toll-like receptor 3 and Toll-like receptor 9 single nucleotide polymorphisms with hepatitis C virus persistence among Egiptians. Arch Virol 163:2433\u20132442","journal-title":"Arch Virol"},{"key":"595_CR24","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1053\/j.gastro.2012.07.099","volume":"143","author":"P Hartmann","year":"2012","unstructured":"Hartmann P, Haimerl M, Mazagova M et al (2012) Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice. Gastroenterology 143:1330\u20131340","journal-title":"Gastroenterology"},{"key":"595_CR25","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1172\/JCI128262","volume":"129","author":"C Hernandez","year":"2019","unstructured":"Hernandez C, Huebener T, Pradere JP et al (2019) HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. J Clin Investig 129:1803","journal-title":"J Clin Investig"},{"key":"595_CR26","first-page":"908","volume":"25","author":"HR Hou","year":"2017","unstructured":"Hou HR, Kang Y, Li YK et al (2017) Hepatitis B core antigen promotes invasion of hepatocellular carcinoma cell line HepG2.2 via Toll-like receptor 4. Zhonghua Gan Zang Bing Za Zhi 25:908\u2013913","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"595_CR27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.autrev.2007.11.006","volume":"7","author":"J Hurst","year":"2008","unstructured":"Hurst J, von Landenberg P (2008) Toll-like receptors and autoimmunity. Autoimmun Rev 7:204\u2013208","journal-title":"Autoimmun Rev"},{"key":"595_CR28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/1743-422X-9-126","volume":"9","author":"M Imran","year":"2012","unstructured":"Imran M, Waheed Y, Manzoor S et al (2012) Interaction of Hepatitis C virus proteins with pattern recognition receptors. Virol J 9:126","journal-title":"Virol J"},{"key":"595_CR29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.molmet.2018.05.015","volume":"14","author":"L Jia","year":"2018","unstructured":"Jia L, Chang X, Qian S et al (2018) Hepatocyte Toll-like receptor 4 deficiency protects against alcohol-induced fatty liver disease. Mol Metab 14:121\u2013129","journal-title":"Mol Metab"},{"key":"595_CR30","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3390\/vaccines6010013","volume":"6","author":"P Kalantari","year":"2018","unstructured":"Kalantari P (2018) The emerging role of pattern recognition receptors in pathogenesis of malaria. Vaccines 6:E13","journal-title":"Vaccines"},{"key":"595_CR31","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clinre.2017.10.002","volume":"42","author":"S Katrinli","year":"2018","unstructured":"Katrinli S, Nigdelioglu A, Ozdil K et al (2018) The association of variations in TLR genes and spontaneous immune control of hepatitis B virus. Clin Res Hepatol Gastroenterol 42:139\u2013144","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"595_CR32","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4254\/wjh.v8.i32.1354","volume":"8","author":"S Kiziltas","year":"2016","unstructured":"Kiziltas S (2016) Toll-like receptors in pathophysiology of liver diseases. World J Hepatol 8:1354\u20131369","journal-title":"World J Hepatol"},{"key":"595_CR33","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1172\/JCI28349","volume":"116","author":"KS Lang","year":"2006","unstructured":"Lang KS, Georgiev P, Recher M et al (2006) Immunoprivileged status of the liver is controlled by toll-like receptor 3 signaling. J Clin Investig 116:2456\u20132463","journal-title":"J Clin Investig"},{"key":"595_CR34","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0092-8674(00)80172-5","volume":"86","author":"B Lemaitre","year":"1996","unstructured":"Lemaitre B, Nicolas E, Michaut L et al (1996) The dorsoventral regulatory gene cassette spatzle\/Toll\/cactus controls to potent antgifungal response in Drosophila adults. Cell 86:973\u2013983","journal-title":"Cell"},{"key":"595_CR35","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","volume":"102","author":"K Li","year":"2005","unstructured":"Li K, Foy E, Ferreon JC et al (2005) Immune evasion by hepatitis C virus NS3\/4A protease toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci USA 102:2992\u20132997","journal-title":"Proc Natl Acad Sci USA"},{"key":"595_CR36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2893.2008.01011.x","volume":"16","author":"NA Libri","year":"2009","unstructured":"Libri NA, Barker SJ, Rosenberg WM et al (2009) A class C CpG toll-like receptor 9 agonist successfully induces robust interferon-alpha production by plasmacytoid dendritic cells from patients chronically infected with hepatitis C. J Viral Hepatol 16:315\u2013324","journal-title":"J Viral Hepatol"},{"key":"595_CR37","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.4049\/jimmunol.1302427","volume":"191","author":"R Medzhitov","year":"2013","unstructured":"Medzhitov R (2013) Pattern recognition theory and the launch of modern innate immunity. J Immunol 191:4473\u20134474","journal-title":"J Immunol"},{"key":"595_CR38","first-page":"278","volume":"10","author":"SY Mohamed","year":"2017","unstructured":"Mohamed SY, Mostafa EF, Hanafy AS et al (2017) The relationship between expression of Toll-like receptor 4 in chronic hepatitis C patients and different stages of liver fibrosis. Gastroenterol Hepatol Bed Bench 10:278\u2013283","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"595_CR39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/08820139.2018.1527851","volume":"48","author":"YM Mosaad","year":"2019","unstructured":"Mosaad YM, Metwally SS, Farag RE et al (2019) Association between Toll-like receptor 3 (TLR3) rs 3775290, TLR7rs 179008, TLR9rs 352140 and chronic HCV infection. Immunol Investig 48:321\u2013332","journal-title":"Immunol Investig"},{"key":"595_CR40","first-page":"e16421","volume":"14","author":"M Motavaf","year":"2014","unstructured":"Motavaf M, Noorbakhsh F, Alavian SM et al (2014) Distinct Toll-like receptor 3 and 7 expression in peripheral blood mononuclear cells from patients with chronic hepatitis C infection. Hepatol Mon 14:e16421","journal-title":"Hepatol Mon"},{"key":"595_CR41","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1152\/physrev.00009.2014","volume":"95","author":"V Motta","year":"2015","unstructured":"Motta V, Soares F, Sun T et al (2015) NOD-like receptors: versatile cytosolic sentinels. Physiol Rev 95:149\u2013178","journal-title":"Physiol Rev"},{"key":"595_CR42","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00005-010-0087-9","volume":"58","author":"I Mozer-Lisewska","year":"2010","unstructured":"Mozer-Lisewska I, Sikora J, Kowala-Piaskowska A et al (2010) The incidence and significance of pattern recognition receptors in chronic viral hepatitis B and C in man. Arch Immunol Ther Exp 58:295\u2013302","journal-title":"Arch Immunol Ther Exp"},{"key":"595_CR43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.intimp.2019.02.016","volume":"70","author":"J Ou","year":"2019","unstructured":"Ou J, Yuan Z, Wang G et al (2019) The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice. Int Immunopharmacol 70:147\u2013155","journal-title":"Int Immunopharmacol"},{"key":"595_CR44","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/jhep.2003.50182","volume":"37","author":"YH Paik","year":"2003","unstructured":"Paik YH, Schwabe RF, Bataller F et al (2003) Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37:1043\u20131055","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"595_CR45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/jgh.12020","volume":"28","author":"J Petrasek","year":"2013","unstructured":"Petrasek J, Csak T, Ganz M (2013) Differences in innate immune signaling between alcoholic and non-alcoholic steatohepatitis. J Gastroenterol Hepatol 28(Suppl 1):93\u201398","journal-title":"J Gastroenterol Hepatol"},{"key":"595_CR46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1053\/j.gastro.2005.10.055","volume":"130","author":"S Radaeva","year":"2006","unstructured":"Radaeva S, Sun R, Jaruga B et al (2006) Natural killer cells ameliorate liver fibrosis by activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis- inducing ligand-dependent manners. Gastroenterology 130:435\u2013452","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"595_CR47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/jgh.12019","volume":"28","author":"YS Roh","year":"2013","unstructured":"Roh YS, Seki E (2013) Toll-like receptors in alcoholic liver disease non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol 28(Suppl 1):38\u201342","journal-title":"J Gastroenterol Hepatol"},{"key":"595_CR48","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/B978-0-12-387664-5.00003-0","volume":"109","author":"D Schenten","year":"2011","unstructured":"Schenten D, Medzhitov R (2011) The control of adaptive immune responses by the innate immune system. Adv Immunol 109:87\u2013124","journal-title":"Adv Immunol"},{"key":"595_CR49","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki E, De Minicis C, Osterreicher H et al (2007) TLR4 enhances TGF-beta signaling and hepatic signaling. Nat Med 13:1324\u20131332","journal-title":"Nat Med"},{"key":"595_CR50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ijc.31029","volume":"142","author":"IJ Song","year":"2018","unstructured":"Song IJ, Yang YM, Inokuchi-Shimizu S et al (2018) The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice. Int J Cancer 142:81\u201391","journal-title":"Int J Cancer"},{"key":"595_CR51","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0000000000003085","volume":"271","author":"RA Sosa","year":"2020","unstructured":"Sosa RA, Rossetti M, Naini BV et al (2020) Pattern recognition receptor-reactivity screening of liver transplant patients: potential for personalized and precise organ matching to reduce risks of ischemia-reperfusion injury. Ann Surg 271:922\u2013931","journal-title":"Ann Surg"},{"issue":"2","key":"595_CR52","doi-asserted-by":"publisher","first-page":"gmr.15027419","DOI":"10.4238\/gmr.15027419","volume":"15","author":"L Sun","year":"2016","unstructured":"Sun L, Dai JJ, Hu WF et al (2016) Expression of toll-like receptors in hepatic cirrhosis and hepatocellular carcinoma. Genet Mol Res 15(2):3. https:\/\/doi.org\/10.4238\/gmr.15027419","journal-title":"Genet Mol Res"},{"key":"595_CR53","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1053\/j.gastro.2018.01.034","volume":"154","author":"A Suslov","year":"2018","unstructured":"Suslov A, Boldanova T, Wang X et al (2018) Hepatitis B virus does not interfere with innate immune responses in the human liver. Gastroenterology 154:1778\u20131790","journal-title":"Gastroenterology"},{"key":"595_CR54","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.1073\/pnas.1002301107","volume":"107","author":"K Takahashi","year":"2010","unstructured":"Takahashi K, Asabe S, Wieland S et al (2010) Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection. Proc Natl Acad Sci USA 107:7431\u20137436","journal-title":"Proc Natl Acad Sci USA"},{"key":"595_CR55","first-page":"805","volume":"37","author":"J Tanaka","year":"2010","unstructured":"Tanaka J, Sugimoto K, Shiraki K et al (2010) Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinoma. Int J Oncol 37:805\u2013814","journal-title":"Int J Oncol"},{"key":"595_CR56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00894-018-3886-2","volume":"19","author":"J Wang","year":"2019","unstructured":"Wang J, Dong R, Zheng S (2019) Role of the inflammasome in the gut-liver axis (review). Mol Med Rep 19:3\u201314","journal-title":"Mol Med Rep"},{"key":"595_CR57","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1128\/JVI.01125-09","volume":"83","author":"N Wang","year":"2009","unstructured":"Wang N, Liang Y, Devaraj S et al (2009) Toll-like receptor 3 mediates establishment of antiviral state against hepatitis C virus in hepatoma cells. J Virol 83:9824\u20139834","journal-title":"J Virol"},{"key":"595_CR58","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/hep.21867","volume":"46","author":"A Watanabe","year":"2007","unstructured":"Watanabe A, Hashmi D, Gomes A et al (2007) Apoptotic hepatocyte DNA inhibits hepatic stellate cell chemotaxis via Toll-like receptor 9. Hepatology 46:1509\u20131518","journal-title":"Hepatology"},{"key":"595_CR59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/vim.2018.0055","volume":"31","author":"K Wei","year":"2018","unstructured":"Wei K, Jiang BC, Guan JH et al (2018) Decreased CD4+, CD2+, CD127dim\/\u2212 regulatory T cells and T helper 17 cell responsiveness to Toll-like receptor 2 in chronic hepatitis patients with Daclatasvir plus Asunaprevir therapy. Viral Immunol 31:559\u2013567","journal-title":"Viral Immunol"},{"key":"595_CR60","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1099\/vir.0.020552-0","volume":"91","author":"S Yu","year":"2010","unstructured":"Yu S, Chen J, Wu M et al (2010) Hepatitis B virus polymerase inhibits RIG-1 and Toll-like receptor 3-mediated beta interferon induction in human hepatocytes through interference with interferon regulatory factor 3 activation and dampening of the interaction between TBK1\/KKepsilon and DDX3. J Gen Virol 91:2080\u20132090","journal-title":"J Gen Virol"},{"key":"595_CR61","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41698-018-0048-z","volume":"2","author":"LX Yu","year":"2018","unstructured":"Yu LX, Ling Y, Wang HY (2018) Role of nonresolving inflammation in hepatocellular carcinoma development and progression. NPJ Precis Oncol 2:6","journal-title":"NPJ Precis Oncol"},{"key":"595_CR62","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1365-2893.2009.01155.x","volume":"17","author":"N Yuki","year":"2010","unstructured":"Yuki N, Matsumoto S, Kato M et al (2010) Hepatic toll-like receptor 3 expression in chronic hepatitis C genotype 1 correlates with treatment response to peginterferon plus ribavirin. J Viral Hepatol 17:130\u2013138","journal-title":"J Viral Hepatol"},{"key":"595_CR63","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31112","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Trippler M, Real C et al (2020) Hepatitis B virus particles activate Toll-like receptor 2 signaling initial upon infection of primary hepatocytes. Hepatology. https:\/\/doi.org\/10.1002\/hep.31112","journal-title":"Hepatology"},{"key":"595_CR64","first-page":"286","volume":"27","author":"DX Zhou","year":"2019","unstructured":"Zhou DX, Ma YJ, Chen GY et al (2019) Relationship of TLR2 and TLR4 expressions on the surface of peripheral blood mononuclear cells to small intestinal bacteria overgrowth in patients with hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi 27:286\u2013290","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"595_CR65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00005-019-00540-x","volume":"67","author":"J \u017beromski","year":"2019","unstructured":"\u017beromski J, Kaczmarek M, Boruczkowski M et al (2019) Significance and role of pattern recognition receptors in malignancy. Arch Immunol Ther Exp 67:133\u2013141","journal-title":"Arch Immunol Ther Exp"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-020-00595-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00005-020-00595-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-020-00595-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T15:49:28Z","timestamp":1704210568000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00005-020-00595-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,17]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["595"],"URL":"https:\/\/doi.org\/10.1007\/s00005-020-00595-1","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,17]]},"assertion":[{"value":"31 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"29"}}